(no title)
6510 | 4 days ago
A lot of entries suggested cheaper versions of existing devices. For less wealthy markets, for prevention, to bring diagnosis closer to the incident and for real time monitoring.
I imagine getting a device approved in a different country might create runway to scale to the domestic market?
No comments yet.